Management of Zinc and Copper Interactions During High‑Dose Iron Therapy

Co‑supplementation Recommendations

When prescribing elemental iron ≥ 100 mg day⁻¹, add zinc to achieve an 8–15 mg zinc : 1 mg copper ratio and monitor both zinc and copper concentrations closely (American College of Endocrinology & American Association of Clinical Endocrinologists) 1.
For regimens delivering 50–100 mg elemental iron day⁻¹, provide at least 15–30 mg elemental zinc daily (Obesity Reviews) 3.
For regimens delivering 150–200 mg elemental iron day⁻¹, provide approximately 30 mg elemental zinc daily and re‑check zinc and copper levels every 3 months (American College of Endocrinology & American Association of Clinical Endocrinologists) 2.
Add 1–2 mg copper for every 8–15 mg zinc to prevent zinc‑induced copper deficiency (American College of Endocrinology & American Association of Clinical Endocrinologists) 1.

Separate iron and zinc doses by 1–2 hours to lessen competitive inhibition at the intestinal divalent‑metal transporter (Obesity Reviews) 3.

In any patient receiving ≥ 100 mg elemental iron daily for > 3 months, obtain baseline serum zinc and copper, then repeat both tests every 3 months (American College of Endocrinology & American Association of Clinical Endocrinologists) 1.
Measure serum zinc together with C‑reactive protein and albumin to allow accurate interpretation (Clinical Nutrition) 6.
Assess serum copper concurrently with ceruloplasmin (American College of Endocrinology & American Association of Clinical Endocrinologists) 2.
Adjust zinc supplementation as needed to keep zinc within the normal range while preserving the 8–15 : 1 zinc‑to‑copper ratio (American College of Endocrinology & American Association of Clinical Endocrinologists) 2.

Prolonged high‑dose iron therapy without zinc and copper monitoring can precipitate zinc deficiency, manifested by impaired wound healing, altered taste, hair loss, and glossitis (Obesity Reviews) 5.
Zinc supplementation without accompanying copper can lead to secondary copper deficiency, presenting with anemia, leukopenia, and myeloneuropathy (American College of Endocrinology & American Association of Clinical Endocrinologists) 1.